Certain Recombinant Factor IX Products; Institution of Investigation, 37898-37899 [2017-17058]
Download as PDF
37898
Federal Register / Vol. 82, No. 155 / Monday, August 14, 2017 / Notices
the ESA by conducting an intra-Service
section 7 consultation on anticipated
ITP actions. We will use the results of
this consultation, in combination with
the above findings, in our final analysis
to determine whether to issue the ITP.
If we determine that all requirements
are met, we will issue an ITP under
section 10(a)(1)(B) of the ESA to the
applicant for the take of the covered
species, incidental to otherwise lawful
covered activities. We will make the
final permit decision no sooner than 30
days after the date of this notice.
Authority
We provide this notice in accordance
with the requirements of section 10 of
the ESA and NEPA and their
implementing regulations (50 CFR 17.32
and 40 CFR 1506.6, respectively).
Dated: June 20, 2017.
Theresa E. Rabot,
Deputy Regional Director, Pacific Region, U.S.
Fish and Wildlife Service, Portland, Oregon.
[FR Doc. 2017–17082 Filed 8–11–17; 8:45 am]
BILLING CODE 4333–15–P
INTERNATIONAL TRADE
COMMISSION
[Investigation No. 337–TA–1066]
Certain Recombinant Factor IX
Products; Institution of Investigation
U.S. International Trade
Commission.
ACTION: Notice.
AGENCY:
Notice is hereby given that a
complaint was filed with the U.S.
International Trade Commission on July
7, 2017, under section 337 of the Tariff
Act of 1930, as amended, on behalf of
Bioverativ Inc. of Waltham,
Massachusetts; Bioverativ Therapeutics
Inc. of Waltham, Massachusetts; and
Bioverativ U.S. LLC of Waltham,
Massachusetts. A supplement to the
complaint was filed on July 14, 2017.
The complaint alleges violations of
section 337 based upon the importation
into the United States, the sale for
importation, and the sale within the
United States after importation of
certain recombinant Factor IX products
by reason of infringement of certain
claims of U.S. Patent No. 9,670,475
(‘‘the ’475 patent’’); U.S. Patent No.
9,623,091 (‘‘the ’091 patent’’); and U.S.
Patent No. 9,629,903 (‘‘the ’903 patent’’).
The complaint further alleges that an
industry in the United States exists as
required by the applicable Federal
Statute.
The complainants request that the
Commission institute an investigation
sradovich on DSK3GMQ082PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
16:45 Aug 11, 2017
Jkt 241001
and, after the investigation, issue a
limited exclusion order and cease and
desist orders.
ADDRESSES: The complaint, except for
any confidential information contained
therein, is available for inspection
during official business hours (8:45 a.m.
to 5:15 p.m.) in the Office of the
Secretary, U.S. International Trade
Commission, 500 E Street SW., Room
112, Washington, DC 20436, telephone
(202) 205–2000. Hearing impaired
individuals are advised that information
on this matter can be obtained by
contacting the Commission’s TDD
terminal on (202) 205–1810. Persons
with mobility impairments who will
need special assistance in gaining access
to the Commission should contact the
Office of the Secretary at (202) 205–
2000. General information concerning
the Commission may also be obtained
by accessing its internet server at
https://www.usitc.gov. The public
record for this investigation may be
viewed on the Commission’s electronic
docket (EDIS) at https://edis.usitc.gov.
FOR FURTHER INFORMATION CONTACT:
Pathenia M. Proctor, The Office of
Unfair Import Investigations, U.S.
International Trade Commission,
telephone (202) 205–2560.
SUPPLEMENTARY INFORMATION:
Authority: The authority for
institution of this investigation is
contained in section 337 of the Tariff
Act of 1930, as amended, 19 U.S.C. 1337
and in section 210.10 of the
Commission’s Rules of Practice and
Procedure, 19 CFR 210.10 (2017).
Scope of Investigation: Having
considered the complaint, the U.S.
International Trade Commission, on
August 8, 2017, ordered that—
(1) Pursuant to subsection (b) of
section 337 of the Tariff Act of 1930, as
amended, an investigation be instituted
to determine whether there is a
violation of subsection (a)(1)(B) of
section 337 in the importation into the
United States, the sale for importation,
or the sale within the United States after
importation of certain recombinant
Factor IX products by reason of
infringement of one or more of claims 1,
2, 4–19, 24, 25, 29, and 34 of the ’475
patent; claims 1–7, 11–16, 18, 19, 21,
and 23–27 of the ’091 patent; and claims
1–10, 13–15, and 17–28 of the ’903
patent; and whether an industry in the
United States exists as required by
subsection (a)(2) of section 337;
(2) Pursuant to Commission Rule
210.50(b)(1), 19 CFR 210.50(b)(1), the
presiding Administrative Law Judge
shall take evidence or other information
and hear arguments from the parties or
other interested persons with respect to
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
the public interest in this investigation,
as appropriate, and provide the
Commission with findings of fact and a
recommended determination on this
issue, which shall be limited to the
statutory public interest factors set forth
in 19 U.S.C. 1337(d)(1), (f)(1), (g)(1);
(3) For the purpose of the
investigation so instituted, the following
are hereby named as parties upon which
this notice of investigation shall be
served:
(a) The complainants are: Bioverativ
Inc., 225 Second Avenue, Waltham, MA
02451. Bioverativ Therapeutics Inc., 225
Second Avenue, Waltham, MA 02451.
Bioverativ U.S. LLC, 225 Second
Avenue, Waltham, MA 02451.
(b) The respondents are the following
entities alleged to be in violation of
section 337, and are the parties upon
which the complaint is to be served:
CSL Behring LLC, 1020 First Avenue,
King of Prussia, PA 19406. CSL Behring
GmbH, Emil-von-Behring-Strasse 76,
Marburg, Hessen 35041 Germany. CSL
Behring Recombinant Facility AG,
Wankdorfstrasse 10, Bern, Bern 3014
Switzerland.
(c) The Office of Unfair Import
Investigations, U.S. International Trade
Commission, 500 E Street SW., Suite
401, Washington, DC 20436; and
(4) For the investigation so instituted,
the Chief Administrative Law Judge,
U.S. International Trade Commission,
shall designate the presiding
Administrative Law Judge.
Responses to the complaint and the
notice of investigation must be
submitted by the named respondents in
accordance with section 210.13 of the
Commission’s Rules of Practice and
Procedure, 19 CFR 210.13. Pursuant to
19 CFR 201.16(e) and 210.13(a), such
responses will be considered by the
Commission if received not later than 20
days after the date of service by the
Commission of the complaint and the
notice of investigation. Extensions of
time for submitting responses to the
complaint and the notice of
investigation will not be granted unless
good cause therefor is shown.
Failure of a respondent to file a timely
response to each allegation in the
complaint and in this notice may be
deemed to constitute a waiver of the
right to appear and contest the
allegations of the complaint and this
notice, and to authorize the
administrative law judge and the
Commission, without further notice to
the respondent, to find the facts to be as
alleged in the complaint and this notice
and to enter an initial determination
and a final determination containing
such findings, and may result in the
issuance of an exclusion order or a cease
E:\FR\FM\14AUN1.SGM
14AUN1
Federal Register / Vol. 82, No. 155 / Monday, August 14, 2017 / Notices
and desist order or both directed against
the respondent.
By order of the Commission.
Issued: August 8, 2017.
Lisa R. Barton,
Secretary to the Commission.
[FR Doc. 2017–17058 Filed 8–11–17; 8:45 am]
BILLING CODE P
INTERNATIONAL TRADE
COMMISSION
[Investigation No. 337–TA–1065]
Certain Mobile Electronic Devices and
Radio Frequency and Processing
Components Thereof; Institution of
Investigation
U.S. International Trade
Commission.
ACTION: Notice.
AGENCY:
Notice is hereby given that a
complaint was filed with the U.S.
International Trade Commission on July
7, 2017, under section 337 of the Tariff
Act of 1930, as amended, on behalf of
Qualcomm Incorporated of San Diego,
California. A supplement was filed on
July 7, 2017. The complaint, as
supplemented, alleges violations of
section 337 based upon the importation
into the United States, the sale for
importation, and the sale within the
United States after importation of
certain mobile electronic devices and
radio frequency and processing
components thereof by reason of
infringement of U.S. Patent No.
8,633,936 (‘‘the ’936 patent’’); U.S.
Patent No. 8,698,558 (‘‘the ’558 patent’’);
U.S. Patent No. 8,487,658 (‘‘the ’658
patent’’); U.S. Patent No. 8,838,949 (‘‘the
’949 patent’’); U.S. Patent No. 9,535,490
(‘‘the ’490 patent’’); and U.S. Patent No.
9,608,675 (‘‘the ’675 patent’’). The
complaint further alleges that an
industry in the United States exists as
required by the applicable Federal
Statute.
The complainant requests that the
Commission institute an investigation
and, after the investigation, issue a
limited exclusion order and a cease and
desist order.
ADDRESSES: The complaint, except for
any confidential information contained
therein, is available for inspection
during official business hours (8:45 a.m.
to 5:15 p.m.) in the Office of the
Secretary, U.S. International Trade
Commission, 500 E Street SW., Room
112, Washington, DC 20436, telephone
(202) 205–2000. Hearing impaired
individuals are advised that information
on this matter can be obtained by
contacting the Commission’s TDD
sradovich on DSK3GMQ082PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
16:45 Aug 11, 2017
Jkt 241001
terminal on (202) 205–1810. Persons
with mobility impairments who will
need special assistance in gaining access
to the Commission should contact the
Office of the Secretary at (202) 205–
2000. General information concerning
the Commission may also be obtained
by accessing its internet server at
https://www.usitc.gov. The public
record for this investigation may be
viewed on the Commission’s electronic
docket (EDIS) at https://edis.usitc.gov.
FOR FURTHER INFORMATION CONTACT:
Pathenia M. Proctor, The Office of
Unfair Import Investigations, U.S.
International Trade Commission,
telephone (202) 205–2560.
SUPPLEMENTARY INFORMATION:
Authority: The authority for
institution of this investigation is
contained in section 337 of the Tariff
Act of 1930, as amended, 19 U.S.C. 1337
and in section 210.10 of the
Commission’s Rules of Practice and
Procedure, 19 CFR 210.10 (2017).
Scope of Investigation: Having
considered the complaint, the U.S.
International Trade Commission, on
August 8, 2017, ordered that—
(1) Pursuant to subsection (b) of
section 337 of the Tariff Act of 1930, as
amended, an investigation be instituted
to determine whether there is a
violation of subsection (a)(1)(B) of
section 337 in the importation into the
United States, the sale for importation,
or the sale within the United States after
importation of certain mobile electronic
devices and radio frequency and
processing components thereof by
reason of infringement of one or more of
claims 1–27, 29, 38, 49, 55–60, 67, and
68 of the ’936 patent; claims 1 and 6–
20 of the ’558 patent; claims 9, 10, 12,
14, and 20–22 of the ’658 patent; claims
1–8, 10–14, 16, 20, and 22 of the ’949
patent; claims 1–6, 8, 10, 16, 17, and 31
of the ’490 patent; and claims 1–3 and
7–14 of the ’675 patent; and whether an
industry in the United States exists as
required by subsection (a)(2) of section
337;
(2) Pursuant to Commission Rule
210.50(b)(1), 19 CFR 210.50(b)(1), the
presiding Administrative Law Judge
shall take evidence or other information
and hear arguments from the parties or
other interested persons with respect to
the public interest in this investigation,
as appropriate, and provide the
Commission with findings of fact and a
recommended determination on this
issue, which shall be limited to the
statutory public interest factors set forth
in 19 U.S.C. 1337(d)(1), (f)(1), (g)(1);
(3) For the purpose of the
investigation so instituted, the following
are hereby named as parties upon which
PO 00000
Frm 00061
Fmt 4703
Sfmt 9990
37899
this notice of investigation shall be
served:
(a) The complainant is: Qualcomm
Incorporated, 5775 Morehouse Drive,
San Diego, CA 92121.
(b) The respondent is the following
entity alleged to be in violation of
section 337, and is the party upon
which the complaint is to be served:
Apple Inc., 1 Infinite Loop, Cupertino,
CA 95014.
(c) The Office of Unfair Import
Investigations, U.S. International Trade
Commission, 500 E Street SW., Suite
401, Washington, DC 20436; and
(4) For the investigation so instituted,
the Chief Administrative Law Judge,
U.S. International Trade Commission,
shall designate the presiding
Administrative Law Judge.
Responses to the complaint and the
notice of investigation must be
submitted by the named respondent in
accordance with section 210.13 of the
Commission’s Rules of Practice and
Procedure, 19 CFR 210.13. Pursuant to
19 CFR 201.16(e) and 210.13(a), such
responses will be considered by the
Commission if received not later than 20
days after the date of service by the
Commission of the complaint and the
notice of investigation. Extensions of
time for submitting responses to the
complaint and the notice of
investigation will not be granted unless
good cause therefor is shown.
Failure of the respondent to file a
timely response to each allegation in the
complaint and in this notice may be
deemed to constitute a waiver of the
right to appear and contest the
allegations of the complaint and this
notice, and to authorize the
administrative law judge and the
Commission, without further notice to
the respondent, to find the facts to be as
alleged in the complaint and this notice
and to enter an initial determination
and a final determination containing
such findings, and may result in the
issuance of an exclusion order or a cease
and desist order or both directed against
the respondent.
By order of the Commission.
Issued: August 8, 2017.
Lisa R. Barton,
Secretary to the Commission.
[FR Doc. 2017–17057 Filed 8–11–17; 8:45 am]
BILLING CODE 7020–02–P
E:\FR\FM\14AUN1.SGM
14AUN1
Agencies
[Federal Register Volume 82, Number 155 (Monday, August 14, 2017)]
[Notices]
[Pages 37898-37899]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-17058]
=======================================================================
-----------------------------------------------------------------------
INTERNATIONAL TRADE COMMISSION
[Investigation No. 337-TA-1066]
Certain Recombinant Factor IX Products; Institution of
Investigation
AGENCY: U.S. International Trade Commission.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: Notice is hereby given that a complaint was filed with the
U.S. International Trade Commission on July 7, 2017, under section 337
of the Tariff Act of 1930, as amended, on behalf of Bioverativ Inc. of
Waltham, Massachusetts; Bioverativ Therapeutics Inc. of Waltham,
Massachusetts; and Bioverativ U.S. LLC of Waltham, Massachusetts. A
supplement to the complaint was filed on July 14, 2017. The complaint
alleges violations of section 337 based upon the importation into the
United States, the sale for importation, and the sale within the United
States after importation of certain recombinant Factor IX products by
reason of infringement of certain claims of U.S. Patent No. 9,670,475
(``the '475 patent''); U.S. Patent No. 9,623,091 (``the '091 patent'');
and U.S. Patent No. 9,629,903 (``the '903 patent''). The complaint
further alleges that an industry in the United States exists as
required by the applicable Federal Statute.
The complainants request that the Commission institute an
investigation and, after the investigation, issue a limited exclusion
order and cease and desist orders.
ADDRESSES: The complaint, except for any confidential information
contained therein, is available for inspection during official business
hours (8:45 a.m. to 5:15 p.m.) in the Office of the Secretary, U.S.
International Trade Commission, 500 E Street SW., Room 112, Washington,
DC 20436, telephone (202) 205-2000. Hearing impaired individuals are
advised that information on this matter can be obtained by contacting
the Commission's TDD terminal on (202) 205-1810. Persons with mobility
impairments who will need special assistance in gaining access to the
Commission should contact the Office of the Secretary at (202) 205-
2000. General information concerning the Commission may also be
obtained by accessing its internet server at https://www.usitc.gov. The
public record for this investigation may be viewed on the Commission's
electronic docket (EDIS) at https://edis.usitc.gov.
FOR FURTHER INFORMATION CONTACT: Pathenia M. Proctor, The Office of
Unfair Import Investigations, U.S. International Trade Commission,
telephone (202) 205-2560.
SUPPLEMENTARY INFORMATION:
Authority: The authority for institution of this investigation is
contained in section 337 of the Tariff Act of 1930, as amended, 19
U.S.C. 1337 and in section 210.10 of the Commission's Rules of Practice
and Procedure, 19 CFR 210.10 (2017).
Scope of Investigation: Having considered the complaint, the U.S.
International Trade Commission, on August 8, 2017, ordered that--
(1) Pursuant to subsection (b) of section 337 of the Tariff Act of
1930, as amended, an investigation be instituted to determine whether
there is a violation of subsection (a)(1)(B) of section 337 in the
importation into the United States, the sale for importation, or the
sale within the United States after importation of certain recombinant
Factor IX products by reason of infringement of one or more of claims
1, 2, 4-19, 24, 25, 29, and 34 of the '475 patent; claims 1-7, 11-16,
18, 19, 21, and 23-27 of the '091 patent; and claims 1-10, 13-15, and
17-28 of the '903 patent; and whether an industry in the United States
exists as required by subsection (a)(2) of section 337;
(2) Pursuant to Commission Rule 210.50(b)(1), 19 CFR 210.50(b)(1),
the presiding Administrative Law Judge shall take evidence or other
information and hear arguments from the parties or other interested
persons with respect to the public interest in this investigation, as
appropriate, and provide the Commission with findings of fact and a
recommended determination on this issue, which shall be limited to the
statutory public interest factors set forth in 19 U.S.C. 1337(d)(1),
(f)(1), (g)(1);
(3) For the purpose of the investigation so instituted, the
following are hereby named as parties upon which this notice of
investigation shall be served:
(a) The complainants are: Bioverativ Inc., 225 Second Avenue,
Waltham, MA 02451. Bioverativ Therapeutics Inc., 225 Second Avenue,
Waltham, MA 02451. Bioverativ U.S. LLC, 225 Second Avenue, Waltham, MA
02451.
(b) The respondents are the following entities alleged to be in
violation of section 337, and are the parties upon which the complaint
is to be served: CSL Behring LLC, 1020 First Avenue, King of Prussia,
PA 19406. CSL Behring GmbH, Emil-von-Behring-Strasse 76, Marburg,
Hessen 35041 Germany. CSL Behring Recombinant Facility AG,
Wankdorfstrasse 10, Bern, Bern 3014 Switzerland.
(c) The Office of Unfair Import Investigations, U.S. International
Trade Commission, 500 E Street SW., Suite 401, Washington, DC 20436;
and
(4) For the investigation so instituted, the Chief Administrative
Law Judge, U.S. International Trade Commission, shall designate the
presiding Administrative Law Judge.
Responses to the complaint and the notice of investigation must be
submitted by the named respondents in accordance with section 210.13 of
the Commission's Rules of Practice and Procedure, 19 CFR 210.13.
Pursuant to 19 CFR 201.16(e) and 210.13(a), such responses will be
considered by the Commission if received not later than 20 days after
the date of service by the Commission of the complaint and the notice
of investigation. Extensions of time for submitting responses to the
complaint and the notice of investigation will not be granted unless
good cause therefor is shown.
Failure of a respondent to file a timely response to each
allegation in the complaint and in this notice may be deemed to
constitute a waiver of the right to appear and contest the allegations
of the complaint and this notice, and to authorize the administrative
law judge and the Commission, without further notice to the respondent,
to find the facts to be as alleged in the complaint and this notice and
to enter an initial determination and a final determination containing
such findings, and may result in the issuance of an exclusion order or
a cease
[[Page 37899]]
and desist order or both directed against the respondent.
By order of the Commission.
Issued: August 8, 2017.
Lisa R. Barton,
Secretary to the Commission.
[FR Doc. 2017-17058 Filed 8-11-17; 8:45 am]
BILLING CODE P